Avinger announces strategic partnership and up to $15 million equity funding agreement with zylox-tonbridge

Initial $7.5 million strategic investment strategic partnership opens pathway to access greater china market strengthened balance sheet and three-year extension of existing debt terms redwood city, ca / accesswire / march 6, 2024 / avinger, inc. (nasdaq:avgr), a commercial-stage medical device company developing and marketing the first and only intravascular image-guided, catheter-based systems for diagnosis and treatment of vascular disease, today announced a new strategic partnership with zylox-tonbridge medical technology co., ltd. (2190.hk, "zylox-tonbridge"), a leading medical device company in the neuro- and peripheral-vascular interventional market in china.
AVGR Ratings Summary
AVGR Quant Ranking